SCHEMBL218358

SCHEMBL218358

CCc1cccc2c1[CH]c1ccccc1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.40
GABRB2 P47870 4/20 0.40
CYP2D6 P10635 1/20 0.37
PDK2 Q15119 1/20 0.36
LMNA P02545 2/20 0.33
MGLL Q99685 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
CSNK2A3 Q8NEV1 1/20 0.33
ANPEP P15144 2/20 0.33
DPP4 P27487 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219160 0.85 NR1H2 (0.34) NR1H2NR1H3
SCHEMBL6647970 0.83 HSPA5 (0.34) CYP2D6LMNADPP4ALDH1A1MAPT
SCHEMBL215717 0.82 NR1H2 (0.42) CYP2D6NR1H2NR1H3
SCHEMBL216507 0.80 NR1H2 (0.48) NR1H2NR1H3
SCHEMBL2974985 0.80 TRPA1 (0.30) ALDH1A1
SCHEMBL2690047 0.79 NPC1 (0.33) CYP2D6LMNACSNK2A2CSNK2BCSNK2A1
SCHEMBL3681441 0.79 RIPK1 (0.39)
SCHEMBL2972881 0.79 NR1H2 (0.50) NR1H2NR1H3
SCHEMBL216255 0.79 NR1H2 (0.50) NR1H2NR1H3
SCHEMBL218348 0.79 NR1H2 (0.50) NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4388019-A1 MODULATING CO-MONOMER SELECTIVITY USING NON-COVALENT DISPERSION INTERACTIONS IN GROUP 4 OLEFIN POLYMERIZATION CATALYSTS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-06-26 EP claimed
WO-2023023455-A1 MODULATING CO-MONOMER SELECTIVITY USING NON-COVALENT DISPERSION INTERACTIONS IN GROUP 4 OLEFIN POLYMERIZATION CATALYSTS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2023-02-23 WO claimed
US-9447211-B2 Preparation method of catalyst for polyolefin polymerization and preparation method of polyolefin LG CHEM, LTD. (KR) 2016-09-20 US claimed
EP-2837640-B1 METHOD FOR PRODUCING CATALYST FOR POLYOLEFIN POLYMERIZATION AND METHOD FOR PREPARING POLYOLEFIN LG CHEMICAL LTD (KR) 2016-09-07 EP claimed
CN-104254547-B The preparation method of catalyst and polyolefinic preparation method for polyolefin polymerization LG化学株式会社 2016-06-08 CN claimed
US-20160152742-A1 PREPARATION METHOD OF CATALYST FOR POLYOLEFIN POLYMERIZATION AND PREPARATION METHOD OF POLYOLEFIN LG CHEM, LTD. (KR) 2016-06-02 US claimed
EP-1910427-B1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS SK INNOVATION CO LTD (KR) 2015-05-13 EP claimed
CN-102977154-B Preparation method of organic-transition metal hydride complexes containing aryl group or alkyl group HANWHA CHEMICAL CORP 2015-05-06 CN claimed
EP-2837640-A1 METHOD FOR PRODUCING CATALYST FOR POLYOLEFIN POLYMERIZATION AND METHOD FOR PREPARING POLYOLEFIN LG Chem, Ltd. (KR) 2015-02-18 EP claimed
CN-104254547-A METHOD FOR PRODUCING CATALYST FOR POLYOLEFIN POLYMERIZATION AND METHOD FOR PREPARING POLYOLEFIN LG CHEMICAL LTD 2014-12-31 CN claimed
US-20100036145-A1 MORE ADVANCED PREPARATION METHOD OF ORGANIC-TRANSITION METAL HYDRIDE COMPLEXES CONTAINING ARYL GROUP OR ALKYL GROUP AS HYDROGEN STORAGE MATERIALS HANWHA CHEMICAL CORPORATION (KP) 2010-02-11 US claimed
US-20090326175-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND a-OLEFINS SK ENERGY CO., LTD. (KR) 2009-12-31 US claimed
US-7589042-B2 Arylphenoxy catalyst system for producing ethylene homopolymer or copolymers of ethylene and α-olefins SK CORPORATION (KR) 2009-09-15 US claimed
EP-2076551-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND -OLEFINS SK Energy Co., Ltd. (KR) 2009-07-08 EP claimed
WO-2008047957-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND α-OLEFINS SK ENERGY CO., LTD. (KR) 2008-04-24 WO claimed
EP-1910427-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS SK Energy Co., Ltd. (KR) 2008-04-16 EP claimed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
US-20070135297-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND a-OLEFINS SK CORPORATION (KR) 2007-06-14 US claimed
WO-2007040294-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS SK ENERGY CO., LTD. (KR) 2007-04-12 WO claimed
US-20070004586-A1 Arylphenoxy catalyst system for producing ethylene homopolymer or copolymers of ethylene and alpha-olefins SK CORPORATION (KR) 2007-01-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036145-A1 MORE ADVANCED PREPARATION METHOD OF ORGANIC-TRANSITION METAL HYDRIDE COMPLEXES CONTAINING ARYL GROUP OR ALKYL GROUP AS HYDROGEN STORAGE MATERIALS H1-10, HDAC10, TIMM10 GABRA1 4667/4885GABRB2 4726/4885CYP2D6 1850/4885
US-20090326175-A1 ARYLPHENOXY CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR COPOLYMERS OF ETHYLENE AND a-OLEFINS ESR1, ERO1A, PPOX GABRA1 2919/4885GABRB2 2439/4885CYP2D6 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.